warning letter

Manufacturing

Glenmark finds itself in the FDA's compliance crosshairs

When drugmakers cut corners on manufacturing investigations, they expose themselves to FDA rebukes—a lesson Glenmark is learning the hard way.
Fraiser Kansteiner Dec 7, 2022 12:02am

In so many words, FDA admonishes drug manufacturer Nephron

Oct 27, 2022 10:13am

Troubled Lupin plant in Tarapur still running afoul of the FDA

Sep 30, 2022 12:43pm

FDA cracks down on Amazon for unapproved mole removal products

Aug 9, 2022 3:45pm

Aurobindo is closing its Aurolife Pharma plant in New Jersey

Mar 23, 2022 12:58pm

Toyobo was slapped with an FDA warning letter

Aug 26, 2021 9:03am